Gene · 407014
Papers3,611
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,611
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-212 Promotes Cardiomyocyte Hypertrophy through Regulating Transcription Factor 7 Like 2. | Mediators Inflamm | 2022 | 36060928 | PubTator, text mining | PubMed |
| Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications. | Front Oncol | 2022 | 36059609 | PubTator, text mining | PubMed |
| Machine learning: A non-invasive prediction method for gastric cancer based on a survey of lifestyle behaviors. | Front Artif Intell | 2022 | 36052291 | PubTator, text mining | PubMed |
| Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression. | Genes Genomics | 2022 | 36040683 | PubTator, text mining | PubMed |
| Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma. | J Clin Lab Anal | 2022 | 36036748 | PubTator, text mining | PubMed |
| Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis. | Front Pharmacol | 2022 | 36034858 | PubTator, text mining | PubMed |
| Review: New horizons in retinoblastoma treatment: an updated review article. | Mol Vis | 2022 | 36034735 | PubTator, text mining | PubMed |
| Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients. | Front Immunol | 2022 | 36032130 | PubTator, text mining | PubMed |
| MicroRNAs as Regulators of Cancer Cell Energy Metabolism. | J Pers Med | 2022 | 36013278 | PubTator, text mining | PubMed |
| The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer. | J Pers Med | 2022 | 36013176 | PubTator, text mining | PubMed |
| Helicobacter pylori Infection and Chronic Immune Thrombocytopenia. | J Clin Med | 2022 | 36013059 | PubTator, text mining | PubMed |
| Using ncRNAs as Tools in Cancer Diagnosis and Treatment-The Way towards Personalized Medicine to Improve Patients' Health. | Int J Mol Sci | 2022 | 36012617 | PubTator, text mining | PubMed |
| Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma. | Int J Mol Sci | 2022 | 36012529 | PubTator, text mining | PubMed |
| Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review. | Int J Mol Sci | 2022 | 36012417 | PubTator, text mining | PubMed |
| Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets. | Int J Mol Sci | 2022 | 36012138 | PubTator, text mining | PubMed |
| Epigenetic Alterations in Sports-Related Injuries. | Genes (Basel) | 2022 | 36011382 | PubTator, text mining | PubMed |
| MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools. | Cancers (Basel) | 2022 | 36010971 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Tumor Microenvironment of Adenocarcinoma of the Stomach, Colon, and Rectum. | Cancers (Basel) | 2022 | 36010940 | PubTator, text mining | PubMed |
| Role of microRNAs in B-Cell Compartment: Development, Proliferation and Hematological Diseases. | Biomedicines | 2022 | 36009551 | PubTator, text mining | PubMed |
| Effects and Mechanisms of Curcumin for the Prevention and Management of Cancers: An Updated Review. | Antioxidants (Basel) | 2022 | 36009200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407014/papers?page=28